The BRYLINTA brand, founded in 2009 (Sweden), from 585 sister brands and 17478 competing brands. BRYLINTA is owned by ASTRAZENECA, listed on the stock exchange of London The International Securities Identification Number (ISIN) of ASTRAZENECA is GB0009895292. BRYLINTA is part of the Drug Manufacturers activity sector.